Intercalated chemotherapy + tyrosine kinase inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intercalated chemotherapy + tyrosine kinase inhibitors, covering 2016-03-29 to 2016-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer [Phase 4]